These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9802875)

  • 21. Pressure-programmable shunt valves.
    Dickerman RD; Colleb K; Morganb JT; Schneiderb S
    J Neurosurg; 2006 Apr; 104(4 Suppl):294; author reply 294. PubMed ID: 16619646
    [No Abstract]   [Full Text] [Related]  

  • 22. Shunt malfunctions.
    Lo P; Drake JM
    Neurosurg Clin N Am; 2001 Oct; 12(4):695-701, viii. PubMed ID: 11524290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A theoretical study of new types of valve shunts for cerebrospinal fluid.
    Bosio A
    ASAIO Trans; 1991; 37(3):M289-90. PubMed ID: 1751154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF shunts 50 years on--past, present and future.
    Drake JM; Kestle JR; Tuli S
    Childs Nerv Syst; 2000 Nov; 16(10-11):800-4. PubMed ID: 11151733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival rates of gravity-assisted, adjustable differential pressure valves in infants with hydrocephalus.
    Gebert AF; Schulz M; Schwarz K; Thomale UW
    J Neurosurg Pediatr; 2016 May; 17(5):544-51. PubMed ID: 26799410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shunt failure caused by valve collapse.
    Lundar T; Langmoen IA; Hovind KH
    J Neurol Neurosurg Psychiatry; 1991 Jun; 54(6):559-60. PubMed ID: 1880522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of infantile hydrocephalus: "differential-pressure" or "flow-control" valves. A pilot study.
    Jain H; Sgouros S; Walsh AR; Hockley AD
    Childs Nerv Syst; 2000 Apr; 16(4):242-6. PubMed ID: 10855523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of protein, red blood cells and whole blood on PS valve function.
    Baird C; Farner S; Mohr C; Pittman T
    Pediatr Neurosurg; 2002 Oct; 37(4):186-93. PubMed ID: 12372911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Pressure Shunt for Simultaneous Diversion of Ventricular Fluid and Extracerebral Fluid.
    Craig D; Winston KR; Folzenlogen Z; Beauchamp KA
    Pediatr Neurosurg; 2018; 53(1):13-17. PubMed ID: 28934739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Useful components of the shunt tap test for evaluation of shunt malfunction.
    Sood S; Kim S; Ham SD; Canady AI; Greninger N
    Childs Nerv Syst; 1993 Jun; 9(3):157-61; discussion 162. PubMed ID: 8374920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee of the ISPN.
    Di Rocco C; Marchese E; Velardi F
    Childs Nerv Syst; 1994 Jul; 10(5):321-7. PubMed ID: 7954501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of cerebrospinal fluid shunts: part II: overdrainage, loculation, and abdominal complications.
    Browd SR; Gottfried ON; Ragel BT; Kestle JR
    Pediatr Neurol; 2006 Mar; 34(3):171-6. PubMed ID: 16504785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting.
    Kehler U; Kiefer M; Eymann R; Wagner W; Tschan CA; Langer N; Rohde V; Ludwig HC; Gliemroth J; Meier U; Lemcke J; Thomale UW; Fritsch M; Krauss JK; Mirzayan MJ; Schuhmann M; Huthmann A
    Clin Neurol Neurosurg; 2015 Oct; 137():132-6. PubMed ID: 26196478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management with a programmable pressure valve of subdural hematomas caused by a ventriculoperitoneal shunt: case report.
    Kamano S; Nakano Y; Imanishi T; Hattori M
    Surg Neurol; 1991 May; 35(5):381-3. PubMed ID: 2028387
    [No Abstract]   [Full Text] [Related]  

  • 36. Simulation of existing and future electromechanical shunt valves in combination with a model for brain fluid dynamics.
    Elixmann IM; Walter M; Kiefer M; Leonhardt S
    Acta Neurochir Suppl; 2012; 113():77-81. PubMed ID: 22116428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel method for controlling cerebrospinal fluid flow and intracranial pressure by use of a tandem shunt valve system.
    Aihara Y; Kawamata T; Mitsuyama T; Hori T; Okada Y
    Pediatr Neurosurg; 2010; 46(1):12-8. PubMed ID: 20453558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A physical framework for implementing virtual models of intracranial pressure and cerebrospinal fluid dynamics in hydrocephalus shunt testing.
    Venkataraman P; Browd SR; Lutz BR
    J Neurosurg Pediatr; 2016 Sep; 18(3):296-305. PubMed ID: 27203135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
    Meling TR; Egge A; Due-Tønnessen B
    Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quality control of shunt systems--status of automated testing of cerebrospinal fluid drainage systems].
    Walter M; Wabel P; Aschoff A; Steudel WI; Leonhardt S
    Biomed Tech (Berl); 1997; 42 Suppl():5-6. PubMed ID: 9517021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.